Literature DB >> 11097115

Fine-specificity of the anti-CENP-A B-cell autoimmune response.

M Mahler1, R Mierau, M Blüthner.   

Abstract

The major targets recognized by anti-centromere autoantibodies are the three centromere-associated proteins (CENPs) A, B, and C, with apparent molecular masses of 19, 80, and 140 kDa, respectively. Previously a major epitope region on the 19-kDa CENP-A antigen was identified by synthesis of a soluble synthetic 15-mer peptide (amino acids 3-17) to be used in enzyme-linked immunosorbent assay and western blot competition assays. However, no systematic experimental scanning for epitope regions on the CENP-A autoantigen has yet been performed. In this study we scanned the complete CENP-A amino acid sequence for epitopes using 19 previously characterized autoimmune-sera. Overlapping peptides 15 amino acids in length and offset by three amino acids were synthesized on activated membranes, covering the whole CENP-A autoantigen. Probing of the membranes with various anti-centromere sera showed that all epitopes are clustered in the N-terminal 45 amino acids. For fine-mapping of this autoreactive region the N-terminus of CENP-A (amino acids 1-45) was scanned again by probing overlapping 15-mer, 12-mer, 10-mer, 8-mer, 7-mer, 6-mer, and 5-mer peptides, all offset by one amino acid, with anti-centromere sera. In this way we localized two epitope core regions within the N-terminal 45 amino acids, one covering amino acids 2-17, recognized by 17 sera, and the other covering amino acids 22-38, recognized by 18 sera. One serum did not react with CENP-A at all. Several sera seem to recognize overlapping individual epitopes within these two epitope core regions. All sera, however, recognize a sequence motif G/A-P-R/S-R-R.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11097115     DOI: 10.1007/s001090000128

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  6 in total

1.  Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies.

Authors:  Yasmin Akbarali; Jennifer Matousek-Ronck; Laura Hunt; Leslie Staudt; Morris Reichlin; Joel M Guthridge; Judith A James
Journal:  J Autoimmun       Date:  2007-01-08       Impact factor: 7.094

2.  Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182.

Authors:  Theophany Eystathioy; Edward K L Chan; Ken Takeuchi; Michael Mahler; LeeAnne M Luft; Douglas W Zochodne; Marvin J Fritzler
Journal:  J Mol Med (Berl)       Date:  2003-11-04       Impact factor: 4.599

3.  Clinical and serological evaluation of a novel CENP-A peptide based ELISA.

Authors:  Michael Mahler; Liesbeth Maes; Daniel Blockmans; Rene Westhovens; Xavier Bossuyt; Gabriela Riemekasten; Sandra Schneider; Falk Hiepe; Andreas Swart; Irmgard Gürtler; Karl Egerer; Margrit Fooke; Marvin J Fritzler
Journal:  Arthritis Res Ther       Date:  2010-05-20       Impact factor: 5.156

4.  Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis.

Authors:  Elvira Favoino; Liboria Digiglio; Giovanna Cuomo; Isabella E Favia; Vito Racanelli; Gabriele Valentini; Federico Perosa
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

5.  An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor.

Authors:  Astrid Behnert; Marvin J Fritzler; Beina Teng; Meifeng Zhang; Frank Bollig; Hermann Haller; Andrej Skoberne; Michael Mahler; Mario Schiffer
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

Review 6.  Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.

Authors:  Mandy Sowa; Rico Hiemann; Peter Schierack; Dirk Reinhold; Karsten Conrad; Dirk Roggenbuck
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.